A director at Crescent NV bought 134,160,256 shares at 0.007EUR and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
1H25 revenues landed at €6.5m growing 12% y/y (26% h/h) below our €8mE. Gross margins kept up well at a high 60%. Ongoing cost efficiencies show off with FTE's down to 154 vs. 169 at year end. EBITDA stood at €-8.2m (vs. €-6.4m in 1H24 and our €-6.9mE). Guidance remained unchanged calling for FY25 revenues to grow in the 50-70% range. We are currently at the mid point of this range. In order to reach this forecast, 2H25 revenues should grow >115% y/y and >70% sequentially (h/h). We remain cautio...
Today NX Filtration is hosting an in person CMD at its Hengelo HQ which we are attending. At the event the company will present its strategy to drive growth and its new medium-term objectives. The FY25 guidance calling for revenues growing 50-70% was reconfirmed but no financial insight into recent contract wins or 1Q25 revenues was given. The medium-term targets call for an EBITDA break-even but a more precise timing is not shared and likely to be clarified at the event. We currently bank on EB...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.